BACKGROUND: The quantitative immunochemical faecal occult blood test (qFOBT) has been shown to be an accurate method of identifying significant colorectal neoplasia including cancer and advanced adenomas. This study reports the results of a Singapore population-based colorectal cancer screening event using the qFOBT. METHODS: This event was held as part of a colorectal cancer awareness exhibition. All asymptomatic individuals above the age of 40 years with no previous colorectal cancer screening in the last 1 year were invited to participate. Eligible participants were screened using two consecutive qFOBTs with a positive faecal haemoglobin threshold taken at 100 ng/mL. Participants with at least one positive qFOBT result were recalled and advised to undergo colonoscopy. Endoscopic polypectomy or surgery was performed according to colonoscopic findings. RESULTS: A total of 751 (55% male, 45% female) participants with a median age of 53 years (range, 40-85 years) took part in the screening event. Five hundred and forty (72%) participants returned the qFOBT samples, of which 57 (11%) tested positive. Fifty-two of these participants proceeded to colonoscopy. Three participants had sigmoid cancer and 12 had advanced polyps, all of which were located distally in the sigmoid colon or rectum. Five of the participants required surgery for colorectal neoplasia and all recovered well without complications. CONCLUSION: The qFOBT at a positive faecal haemoglobin threshold of 100 ng/ml has a high positive predictive value and is an effective screening tool for colorectal cancer in an Asian population.
BACKGROUND: The quantitative immunochemical faecal occult blood test (qFOBT) has been shown to be an accurate method of identifying significant colorectal neoplasia including cancer and advanced adenomas. This study reports the results of a Singapore population-based colorectal cancer screening event using the qFOBT. METHODS: This event was held as part of a colorectal cancer awareness exhibition. All asymptomatic individuals above the age of 40 years with no previous colorectal cancer screening in the last 1 year were invited to participate. Eligible participants were screened using two consecutive qFOBTs with a positive faecal haemoglobin threshold taken at 100 ng/mL. Participants with at least one positive qFOBT result were recalled and advised to undergo colonoscopy. Endoscopic polypectomy or surgery was performed according to colonoscopic findings. RESULTS: A total of 751 (55% male, 45% female) participants with a median age of 53 years (range, 40-85 years) took part in the screening event. Five hundred and forty (72%) participants returned the qFOBT samples, of which 57 (11%) tested positive. Fifty-two of these participants proceeded to colonoscopy. Three participants had sigmoid cancer and 12 had advanced polyps, all of which were located distally in the sigmoid colon or rectum. Five of the participants required surgery for colorectal neoplasia and all recovered well without complications. CONCLUSION: The qFOBT at a positive faecal haemoglobin threshold of 100 ng/ml has a high positive predictive value and is an effective screening tool for colorectal cancer in an Asian population.
Authors: Alex Vilkin; Paul Rozen; Zohar Levi; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Yaron Niv Journal: Am J Gastroenterol Date: 2005-11 Impact factor: 10.864
Authors: P D Greenberg; L Bertario; R Gnauck; O Kronborg; J D Hardcastle; M S Epstein; D Sadowski; R Sudduth; G R Zuckerman; D C Rockey Journal: Am J Gastroenterol Date: 2000-05 Impact factor: 10.864
Authors: Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv Journal: Ann Intern Med Date: 2007-02-20 Impact factor: 25.391
Authors: J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham Journal: Lancet Date: 1996-11-30 Impact factor: 79.321
Authors: Wai Man Wong; Shiu Kum Lam; Kwan Lok Cheung; Teresa Sze Man Tong; Paul Rozen; Graeme P Young; Kin Wah Chu; Judy Ho; Wai Lun Law; Hiu Ming Tung; Hok Kwok Choi; Yee Man Lee; Kam Chuen Lai; Wayne H C Hu; Chi Kuen Chan; Man Fung Yuen; Benjamin Chun-Yu Wong Journal: Cancer Date: 2003-05-15 Impact factor: 6.860
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer Journal: Gastroenterology Date: 2008-02-08 Impact factor: 22.682
Authors: James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby Journal: J Natl Cancer Inst Date: 2007-09-25 Impact factor: 13.506
Authors: S Ciatto; F Martinelli; G Castiglione; P Mantellini; T Rubeca; G Grazzini; A G Bonanomi; M Confortini; M Zappa Journal: Br J Cancer Date: 2007-01-09 Impact factor: 7.640
Authors: Chi Thi-Du Tran; Mai Vu-Tuyet Nguyen; Mo Thi Tran; Thuy Thi-Van Tuong; Quang Hong Tran; Linh Cu Le; Huong Thi-Thu Pham; Nam Chi Bui; Hien Huy Vu; Tu Thi-Cam Nguyen; Phuong Que Ta; Hien Thi-Thu Ha; Dung Tuan Trinh; Hanh Thi-My Bui; Dien Quang Trinh; Khanh Van Nguyen; Song Huu Le; Khien Van Vu; Thuan Van Tran; Huong Thi-Thanh Tran; Martha J Shrubsole; Fei Ye; Qiuyin Cai; Wei Zheng; Paolo Boffetta; Xiao-Ou Shu; Hung N Luu Journal: Jpn J Clin Oncol Date: 2022-07-08 Impact factor: 2.925